enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
2.410
+0.130 (5.70%)
At close: Nov 13, 2026, 4:00 PM EST
2.319
-0.091 (-3.78%)
After-hours: Nov 13, 2026, 7:58 PM EST
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $161.51 million as of November 13, 2026. It is the 21,794th most valuable company in the world and the 3,691st biggest in the United States. Its market cap has decreased by 64.23% in one year.
Market Cap
161.51M
Enterprise Value
-71.54M
1-Year Change
-64.23%
Global Rank
Country Rank
#3,691 United States
Category
ChartMarket Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has increased from $155.91M to $161.51M, an increase of 3.59%. That is a compound annual growth rate of 0.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 161.51M | -73.30% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Spruce Biosciences | 132.78M |
| Abeona Therapeutics | 131.44M |
| Jyong Biotech | 129.17M |
| LENZ Therapeutics | 129.14M |
| Minerva Neurosciences | 127.58M |
| Foghorn Therapeutics | 125.32M |
| Outlook Therapeutics | 117.10M |
| Molecular Partners AG | 115.56M |